We have shown that OX40L-expressing Ewing sarcoma cells preserved the expression of typical Ewing sarcoma-associated antigens and are practicable for immunotherapy protocols with transgenic tumor cells. The gene discussed is TNFSF4; the disease is Ewing sarcoma.